| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |